QT interval prolongation and the risk of malignant ventricular dysrhythmia and/or cardiac arrest: Systematic search and narrative review of risk related to the magnitude of QT interval length
Prolongation of the QTc interval is associated with an increased risk of malignant ventricular dysrhythmias, such as ventricular tachycardia (VT), and sudden cardiac death. The quantifiable risk rates of adverse dysrhythmic outcome in relation to specific QTc interval length are not known. We conduc...
Gespeichert in:
Veröffentlicht in: | The American journal of emergency medicine 2021-11, Vol.49, p.40-47 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 47 |
---|---|
container_issue | |
container_start_page | 40 |
container_title | The American journal of emergency medicine |
container_volume | 49 |
creator | Robison, Lauren B. Brady, William J. Robison, Robert A. Charlton, Nathan |
description | Prolongation of the QTc interval is associated with an increased risk of malignant ventricular dysrhythmias, such as ventricular tachycardia (VT), and sudden cardiac death. The quantifiable risk rates of adverse dysrhythmic outcome in relation to specific QTc interval length are not known. We conducted a literature review on the topic of QT interval prolongation in adult patients and the associated risk of malignant dysrhythmic event. We specifically formulated our literature search and subsequent literature review to address the following question: Can the clinician identify specific QTc intervals at which a specific quantifiable risk of malignant dysrhythmic event (malignant ventricular dysrhythmia and/or cardiac arrest) occurs in an undifferentiated adult patient population? In the literature search, we identified 701 studies; upon review using specific, pre-determined inclusion criteria, we identified 16 articles for inclusion in the review. From this literature, we were unable to answer the question in a quantifiable manner and only noted that the risk of malignant dysrhythmic event increases with progressively longer QTc interval. The current literature on this topic is inadequate to answer this important question due to heterogenous study methodology, patient populations, endpoints, and periods of observation. Additional prospective research is required on this topic, aimed at addressing the important issue of specific, quantifiable risk and its relation to degree of prolongation of the QTc interval. |
doi_str_mv | 10.1016/j.ajem.2021.05.032 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2535829758</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0735675721004150</els_id><sourcerecordid>2535829758</sourcerecordid><originalsourceid>FETCH-LOGICAL-c427t-c6ad31c60f3876bc03b762ad7fcab942527e2d5d2eb1da539b67418a4e8c53373</originalsourceid><addsrcrecordid>eNp9kcuO1DAQRSMEEs3AD7CyxIZNMn7EcRqxQaPhIY2EEMPaqtiVjkPiDLbTqL-OX8PpZoFYsLJUPrduVd2ieMloxShrrscKRpwrTjmrqKyo4I-KHZOCly1T7HGxo0rIslFSPS2exThSylgt613x68s9cT5hOMJEHsIyLf4AyS2egLckDUiCi9_J0pMZJnfw4BM5ok_BmXWCQOwphuGUhtnBprheAjEQrANDIASM6Q35eooJ59zUkIgQzHBu7fN3rh2zAR4d_twszlYBJ0iYvZez_QwH79JqcQP-HnZCf0jD8-JJD1PEF3_eq-Lb-9v7m4_l3ecPn27e3ZWm5iqVpgErmGloL1rVdIaKTjUcrOoNdPuaS66QW2k5dsyCFPuuUTVrocbWSCGUuCpeX_rmG_1Y8156dtHgNIHHZY2aSyFbvleyzeirf9BxWYPP02WqbQXbKyEyxS-UCUuMAXv9ENwM4aQZ1VumetRbpnrLVFOpc6ZZ9PYiwrxqvlrQ0Tj0Bq0LaJK2i_uf_Dd_p660</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2588319733</pqid></control><display><type>article</type><title>QT interval prolongation and the risk of malignant ventricular dysrhythmia and/or cardiac arrest: Systematic search and narrative review of risk related to the magnitude of QT interval length</title><source>Access via ScienceDirect (Elsevier)</source><source>ProQuest Central UK/Ireland</source><creator>Robison, Lauren B. ; Brady, William J. ; Robison, Robert A. ; Charlton, Nathan</creator><creatorcontrib>Robison, Lauren B. ; Brady, William J. ; Robison, Robert A. ; Charlton, Nathan</creatorcontrib><description>Prolongation of the QTc interval is associated with an increased risk of malignant ventricular dysrhythmias, such as ventricular tachycardia (VT), and sudden cardiac death. The quantifiable risk rates of adverse dysrhythmic outcome in relation to specific QTc interval length are not known. We conducted a literature review on the topic of QT interval prolongation in adult patients and the associated risk of malignant dysrhythmic event. We specifically formulated our literature search and subsequent literature review to address the following question: Can the clinician identify specific QTc intervals at which a specific quantifiable risk of malignant dysrhythmic event (malignant ventricular dysrhythmia and/or cardiac arrest) occurs in an undifferentiated adult patient population? In the literature search, we identified 701 studies; upon review using specific, pre-determined inclusion criteria, we identified 16 articles for inclusion in the review. From this literature, we were unable to answer the question in a quantifiable manner and only noted that the risk of malignant dysrhythmic event increases with progressively longer QTc interval. The current literature on this topic is inadequate to answer this important question due to heterogenous study methodology, patient populations, endpoints, and periods of observation. Additional prospective research is required on this topic, aimed at addressing the important issue of specific, quantifiable risk and its relation to degree of prolongation of the QTc interval.</description><identifier>ISSN: 0735-6757</identifier><identifier>EISSN: 1532-8171</identifier><identifier>DOI: 10.1016/j.ajem.2021.05.032</identifier><language>eng</language><publisher>Philadelphia: Elsevier Inc</publisher><subject>Acute coronary syndromes ; Cardiac arrest ; Cardiac arrhythmia ; Cardiovascular disease ; Clinical trials ; Defibrillators ; Electrocardiography ; Electrolytes ; Emergency medical care ; Heart ; Heart attacks ; Kidney diseases ; Literature reviews ; Malignant ventricular dysrhythmia ; Patients ; Population studies ; Prediction ; QT interval ; QT interval prolongation ; Tachycardia ; Toxicology ; Ventricle ; Ventricular dysrhythmia</subject><ispartof>The American journal of emergency medicine, 2021-11, Vol.49, p.40-47</ispartof><rights>2021 Elsevier Inc.</rights><rights>2021. Elsevier Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c427t-c6ad31c60f3876bc03b762ad7fcab942527e2d5d2eb1da539b67418a4e8c53373</citedby><cites>FETCH-LOGICAL-c427t-c6ad31c60f3876bc03b762ad7fcab942527e2d5d2eb1da539b67418a4e8c53373</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/2588319733?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995,64385,64387,64389,72469</link.rule.ids></links><search><creatorcontrib>Robison, Lauren B.</creatorcontrib><creatorcontrib>Brady, William J.</creatorcontrib><creatorcontrib>Robison, Robert A.</creatorcontrib><creatorcontrib>Charlton, Nathan</creatorcontrib><title>QT interval prolongation and the risk of malignant ventricular dysrhythmia and/or cardiac arrest: Systematic search and narrative review of risk related to the magnitude of QT interval length</title><title>The American journal of emergency medicine</title><description>Prolongation of the QTc interval is associated with an increased risk of malignant ventricular dysrhythmias, such as ventricular tachycardia (VT), and sudden cardiac death. The quantifiable risk rates of adverse dysrhythmic outcome in relation to specific QTc interval length are not known. We conducted a literature review on the topic of QT interval prolongation in adult patients and the associated risk of malignant dysrhythmic event. We specifically formulated our literature search and subsequent literature review to address the following question: Can the clinician identify specific QTc intervals at which a specific quantifiable risk of malignant dysrhythmic event (malignant ventricular dysrhythmia and/or cardiac arrest) occurs in an undifferentiated adult patient population? In the literature search, we identified 701 studies; upon review using specific, pre-determined inclusion criteria, we identified 16 articles for inclusion in the review. From this literature, we were unable to answer the question in a quantifiable manner and only noted that the risk of malignant dysrhythmic event increases with progressively longer QTc interval. The current literature on this topic is inadequate to answer this important question due to heterogenous study methodology, patient populations, endpoints, and periods of observation. Additional prospective research is required on this topic, aimed at addressing the important issue of specific, quantifiable risk and its relation to degree of prolongation of the QTc interval.</description><subject>Acute coronary syndromes</subject><subject>Cardiac arrest</subject><subject>Cardiac arrhythmia</subject><subject>Cardiovascular disease</subject><subject>Clinical trials</subject><subject>Defibrillators</subject><subject>Electrocardiography</subject><subject>Electrolytes</subject><subject>Emergency medical care</subject><subject>Heart</subject><subject>Heart attacks</subject><subject>Kidney diseases</subject><subject>Literature reviews</subject><subject>Malignant ventricular dysrhythmia</subject><subject>Patients</subject><subject>Population studies</subject><subject>Prediction</subject><subject>QT interval</subject><subject>QT interval prolongation</subject><subject>Tachycardia</subject><subject>Toxicology</subject><subject>Ventricle</subject><subject>Ventricular dysrhythmia</subject><issn>0735-6757</issn><issn>1532-8171</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp9kcuO1DAQRSMEEs3AD7CyxIZNMn7EcRqxQaPhIY2EEMPaqtiVjkPiDLbTqL-OX8PpZoFYsLJUPrduVd2ieMloxShrrscKRpwrTjmrqKyo4I-KHZOCly1T7HGxo0rIslFSPS2exThSylgt613x68s9cT5hOMJEHsIyLf4AyS2egLckDUiCi9_J0pMZJnfw4BM5ok_BmXWCQOwphuGUhtnBprheAjEQrANDIASM6Q35eooJ59zUkIgQzHBu7fN3rh2zAR4d_twszlYBJ0iYvZez_QwH79JqcQP-HnZCf0jD8-JJD1PEF3_eq-Lb-9v7m4_l3ecPn27e3ZWm5iqVpgErmGloL1rVdIaKTjUcrOoNdPuaS66QW2k5dsyCFPuuUTVrocbWSCGUuCpeX_rmG_1Y8156dtHgNIHHZY2aSyFbvleyzeirf9BxWYPP02WqbQXbKyEyxS-UCUuMAXv9ENwM4aQZ1VumetRbpnrLVFOpc6ZZ9PYiwrxqvlrQ0Tj0Bq0LaJK2i_uf_Dd_p660</recordid><startdate>202111</startdate><enddate>202111</enddate><creator>Robison, Lauren B.</creator><creator>Brady, William J.</creator><creator>Robison, Robert A.</creator><creator>Charlton, Nathan</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>202111</creationdate><title>QT interval prolongation and the risk of malignant ventricular dysrhythmia and/or cardiac arrest: Systematic search and narrative review of risk related to the magnitude of QT interval length</title><author>Robison, Lauren B. ; Brady, William J. ; Robison, Robert A. ; Charlton, Nathan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c427t-c6ad31c60f3876bc03b762ad7fcab942527e2d5d2eb1da539b67418a4e8c53373</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Acute coronary syndromes</topic><topic>Cardiac arrest</topic><topic>Cardiac arrhythmia</topic><topic>Cardiovascular disease</topic><topic>Clinical trials</topic><topic>Defibrillators</topic><topic>Electrocardiography</topic><topic>Electrolytes</topic><topic>Emergency medical care</topic><topic>Heart</topic><topic>Heart attacks</topic><topic>Kidney diseases</topic><topic>Literature reviews</topic><topic>Malignant ventricular dysrhythmia</topic><topic>Patients</topic><topic>Population studies</topic><topic>Prediction</topic><topic>QT interval</topic><topic>QT interval prolongation</topic><topic>Tachycardia</topic><topic>Toxicology</topic><topic>Ventricle</topic><topic>Ventricular dysrhythmia</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Robison, Lauren B.</creatorcontrib><creatorcontrib>Brady, William J.</creatorcontrib><creatorcontrib>Robison, Robert A.</creatorcontrib><creatorcontrib>Charlton, Nathan</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Immunology Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>The American journal of emergency medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Robison, Lauren B.</au><au>Brady, William J.</au><au>Robison, Robert A.</au><au>Charlton, Nathan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>QT interval prolongation and the risk of malignant ventricular dysrhythmia and/or cardiac arrest: Systematic search and narrative review of risk related to the magnitude of QT interval length</atitle><jtitle>The American journal of emergency medicine</jtitle><date>2021-11</date><risdate>2021</risdate><volume>49</volume><spage>40</spage><epage>47</epage><pages>40-47</pages><issn>0735-6757</issn><eissn>1532-8171</eissn><abstract>Prolongation of the QTc interval is associated with an increased risk of malignant ventricular dysrhythmias, such as ventricular tachycardia (VT), and sudden cardiac death. The quantifiable risk rates of adverse dysrhythmic outcome in relation to specific QTc interval length are not known. We conducted a literature review on the topic of QT interval prolongation in adult patients and the associated risk of malignant dysrhythmic event. We specifically formulated our literature search and subsequent literature review to address the following question: Can the clinician identify specific QTc intervals at which a specific quantifiable risk of malignant dysrhythmic event (malignant ventricular dysrhythmia and/or cardiac arrest) occurs in an undifferentiated adult patient population? In the literature search, we identified 701 studies; upon review using specific, pre-determined inclusion criteria, we identified 16 articles for inclusion in the review. From this literature, we were unable to answer the question in a quantifiable manner and only noted that the risk of malignant dysrhythmic event increases with progressively longer QTc interval. The current literature on this topic is inadequate to answer this important question due to heterogenous study methodology, patient populations, endpoints, and periods of observation. Additional prospective research is required on this topic, aimed at addressing the important issue of specific, quantifiable risk and its relation to degree of prolongation of the QTc interval.</abstract><cop>Philadelphia</cop><pub>Elsevier Inc</pub><doi>10.1016/j.ajem.2021.05.032</doi><tpages>8</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0735-6757 |
ispartof | The American journal of emergency medicine, 2021-11, Vol.49, p.40-47 |
issn | 0735-6757 1532-8171 |
language | eng |
recordid | cdi_proquest_miscellaneous_2535829758 |
source | Access via ScienceDirect (Elsevier); ProQuest Central UK/Ireland |
subjects | Acute coronary syndromes Cardiac arrest Cardiac arrhythmia Cardiovascular disease Clinical trials Defibrillators Electrocardiography Electrolytes Emergency medical care Heart Heart attacks Kidney diseases Literature reviews Malignant ventricular dysrhythmia Patients Population studies Prediction QT interval QT interval prolongation Tachycardia Toxicology Ventricle Ventricular dysrhythmia |
title | QT interval prolongation and the risk of malignant ventricular dysrhythmia and/or cardiac arrest: Systematic search and narrative review of risk related to the magnitude of QT interval length |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T21%3A50%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=QT%20interval%20prolongation%20and%20the%20risk%20of%20malignant%20ventricular%20dysrhythmia%20and/or%20cardiac%20arrest:%20Systematic%20search%20and%20narrative%20review%20of%20risk%20related%20to%20the%20magnitude%20of%20QT%20interval%20length&rft.jtitle=The%20American%20journal%20of%20emergency%20medicine&rft.au=Robison,%20Lauren%20B.&rft.date=2021-11&rft.volume=49&rft.spage=40&rft.epage=47&rft.pages=40-47&rft.issn=0735-6757&rft.eissn=1532-8171&rft_id=info:doi/10.1016/j.ajem.2021.05.032&rft_dat=%3Cproquest_cross%3E2535829758%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2588319733&rft_id=info:pmid/&rft_els_id=S0735675721004150&rfr_iscdi=true |